{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:04:36Z","timestamp":1794974676389,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To report the first experience of our multidisciplinary team with functional imaging using <jats:sup>11<\/jats:sup>C-methionine positron emission tomography-computed tomography (<jats:sup>11<\/jats:sup>C-methionine PET-CT) co-registered with MRI (Met-PET\/MRI<jats:sup>CR<\/jats:sup>) in clinical decision making and surgical planning of patients with difficult to treat prolactinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In eighteen patients with prolactinoma, referred to our tertiary referral centre because of intolerance or resistance for dopamine agonists (DA), Met-PET\/MRI<jats:sup>CR<\/jats:sup> was used to aid decision-making regarding therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Met-PET\/MRI<jats:sup>CR<\/jats:sup> was positive in 94% of the patients. MRI and Met-PET\/MRI<jats:sup>CR<\/jats:sup> findings were completely concordant in five patients, partially concordant in nine patients, and non-concordant in four patients. In five patients Met-PET\/MRI<jats:sup>CR<\/jats:sup> identified lesion(s) that were retrospectively also visible on MRI. Met-PET\/MRI<jats:sup>CR<\/jats:sup> was false negative in one patient, with a cystic adenoma on conventional MRI. Thirteen patients underwent transsphenoidal surgery, with nine achieving full biochemical remission, two clinical improvement and near normalized prolactin levels, and one patient clinical improvement with significant tumour reduction. Hence, nearly all patients (94%) were considered to have a positive outcome. Permanent complication rate was low. Three patients continued DA, two patients have a wait and scan policy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Met-PET\/MRI<jats:sup>CR<\/jats:sup> can provide additional information to guide multidisciplinary preoperative and intraoperative decision making in selected cases of prolactinoma. This approach resulted in a high remission rate with a low rate of complications in our expert centre.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11102-022-01230-2","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:03:15Z","timestamp":1653566595000},"page":"587-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery"],"prefix":"10.1007","volume":"25","author":[{"given":"Leontine E. H.","family":"Bakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco J. T.","family":"Verstegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eidrees","family":"Ghariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit M.","family":"Verbist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waiel A.","family":"Bashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Kruit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-9866","authenticated-orcid":false,"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter R.","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-5554","authenticated-orcid":false,"given":"Lenka M. Pereira Arias","family":"Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"1230_CR1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1668","author":"AF Daly","year":"2006","unstructured":"Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege. Belg J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2006-1668","journal-title":"Belg J Clin Endocrinol Metab"},{"key":"1230_CR2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz144","author":"AH Zamanipoor Najafabadi","year":"2020","unstructured":"Zamanipoor Najafabadi AH, Zandbergen IM, de Vries F, Broersen LHA, van den Akker-van Marle ME, Pereira AM, Peul WC, Dekkers OM, van Furth WR, Biermasz NR (2020) Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz144","journal-title":"J Clin Endocrinol Metab"},{"key":"1230_CR3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA, Endocrine S (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"1230_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0912025","author":"A Klibanski","year":"2010","unstructured":"Klibanski A (2010) Clinical practice. Prolactinomas. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMcp0912025","journal-title":"N Engl J Med"},{"key":"1230_CR5","doi-asserted-by":"publisher","DOI":"10.1530\/eje-16-0087","author":"M Tampourlou","year":"2016","unstructured":"Tampourlou M, Trifanescu R, Paluzzi A, Ahmed SK, Karavitaki N (2016) Therapy of endocrine disease: surgery in microprolactinomas: effectiveness and risks based on contemporary literature. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-16-0087","journal-title":"Eur J Endocrinol"},{"key":"1230_CR6","doi-asserted-by":"publisher","DOI":"10.1530\/eje-15-0616","author":"O Koulouri","year":"2015","unstructured":"Koulouri O, Steuwe A, Gillett D, Hoole AC, Powlson AS, Donnelly NA, Burnet NG, Antoun NM, Cheow H, Mannion RJ, Pickard JD, Gurnell M (2015) A role for 11C-methionine PET imaging in ACTH-dependent Cushing\u2019s syndrome. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-15-0616","journal-title":"Eur J Endocrinol"},{"key":"1230_CR7","doi-asserted-by":"publisher","DOI":"10.1530\/eje-16-0639","author":"O Koulouri","year":"2016","unstructured":"Koulouri O, Kandasamy N, Hoole AC, Gillett D, Heard S, Powlson AS, O\u2019Donovan DG, Annamalai AK, Simpson HL, Akker SA, Aylwin SJ, Brooke A, Buch H, Levy MJ, Martin N, Morris D, Parkinson C, Tysome JR, Santarius T, Donnelly N, Buscombe J, Boros I, Smith R, Aigbirhio F, Antoun NM, Burnet NG, Cheow H, Mannion RJ, Pickard JD, Gurnell M (2016) Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-16-0639","journal-title":"Eur J Endocrinol"},{"key":"1230_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(16)30311-4","author":"O Koulouri","year":"2016","unstructured":"Koulouri O, Hoole AC, English P, Allinson K, Antoun N, Cheow H, Burnet NG, Donnelly N, Mannion RJ, Gurnell M (2016) Localisation of an occult thyrotropinoma with (11)C-methionine PET-CT before and after somatostatin analogue therapy. Lancet Diabetes Endocrinol. https:\/\/doi.org\/10.1016\/s2213-8587(16)30311-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1230_CR9","doi-asserted-by":"publisher","DOI":"10.3171\/2020.3.Focus2052","author":"WA Bashari","year":"2020","unstructured":"Bashari WA, Senanayake R, Koulouri O, Gillett D, MacFarlane J, Powlson AS, Fernandez-Pombo A, Bano G, Martin AJ, Scoffings D, Cheow H, Mendichovszky I, Tysome J, Donnelly N, Santarius T, Kolias A, Mannion R, Gurnell M (2020) PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly. Neurosurg Focus. https:\/\/doi.org\/10.3171\/2020.3.Focus2052","journal-title":"Neurosurg Focus"},{"key":"1230_CR10","doi-asserted-by":"publisher","DOI":"10.1530\/eje-19-0344","author":"DJ Lobatto","year":"2019","unstructured":"Lobatto DJ, Zamanipoor Najafabadi AH, de Vries F, Andela CD, van den Hout WB, Pereira AM, Peul WC, Vliet Vlieland TPM, van Furth WR, Biermasz NR (2019) Toward value based health care in pituitary surgery: application of a comprehensive outcome set in perioperative care. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-19-0344","journal-title":"Eur J Endocrinol"},{"key":"1230_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13242","author":"J Wedman","year":"2019","unstructured":"Wedman J, Pruim J, van der Putten L, Hoekstra OS, de Bree R, van Dijk BAC, van der Laan B (2019) Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy? Clin Otolaryngol. https:\/\/doi.org\/10.1111\/coa.13242","journal-title":"Clin Otolaryngol"},{"key":"1230_CR12","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.Jns141083","author":"AS Micko","year":"2015","unstructured":"Micko AS, W\u00f6hrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg. https:\/\/doi.org\/10.3171\/2014.12.Jns141083","journal-title":"J Neurosurg"},{"key":"1230_CR13","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199310000-00008","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"1230_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01569-6","author":"L Andereggen","year":"2021","unstructured":"Andereggen L, Frey J, Andres RH, Luedi MM, El-Koussy M, Widmer HR, Beck J, Mariani L, Seiler RW, Christ E (2021) First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-021-01569-6","journal-title":"J Endocrinol Invest"},{"key":"1230_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2021.100258","author":"L Andereggen","year":"2021","unstructured":"Andereggen L, Frey J, Andres RH, Luedi MM, Gralla J, Schubert GA, Beck J, Mariani L, Christ E (2021) Impact of primary medical or surgical therapy on prolactinoma patients\u2019 BMI and metabolic profile over the long-term. J Clin Transl Endocrinol. https:\/\/doi.org\/10.1016\/j.jcte.2021.100258","journal-title":"J Clin Transl Endocrinol"},{"key":"1230_CR16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0293","author":"B Baussart","year":"2021","unstructured":"Baussart B, Villa C, Jouinot A, Raffin-Sanson ML, Foubert L, Cazabat L, Bernier M, Bonnet F, Dohan A, Bertherat J, Assie G, Gaillard S (2021) Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-21-0293","journal-title":"Eur J Endocrinol"},{"key":"1230_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000584","author":"TY Chen","year":"2021","unstructured":"Chen TY, Lee CH, Yang MY, Shen CC, Yang YP, Chien Y, Huang YF, Lai CM, Cheng WY (2021) Treatment of hyperprolactinemia: a single-institute experience. J Chin Med Assoc. https:\/\/doi.org\/10.1097\/JCMA.0000000000000584","journal-title":"J Chin Med Assoc"},{"key":"1230_CR18","doi-asserted-by":"publisher","DOI":"10.1055\/a-1247-4908","author":"S Giese","year":"2021","unstructured":"Giese S, Nasi-Kordhishti I, Honegger J (2021) Outcomes of transsphenoidal microsurgery for prolactinomas\u2014a contemporary series of 162 cases. Exp Clin Endocrinol Diabetes. https:\/\/doi.org\/10.1055\/a-1247-4908","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1230_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013198","author":"YL Han","year":"2018","unstructured":"Han YL, Chen DM, Zhang C, Pan M, Yang XP, Wu YG (2018) Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/MD.0000000000013198","journal-title":"Medicine (Baltimore)"},{"key":"1230_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2021.11.008","author":"H Lasolle","year":"2022","unstructured":"Lasolle H, Teulade M, Lapras V, Vasiljevic A, Borson-Chazot F, Jouanneau E, Raverot G (2022) Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience. Ann Endocrinol (Paris). https:\/\/doi.org\/10.1016\/j.ando.2021.11.008","journal-title":"Ann Endocrinol (Paris)"},{"key":"1230_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9930059","author":"J Lu","year":"2021","unstructured":"Lu J, Cai L, Wu Z, Lin W, Xu J, Zhu Z, Wang C, Li Q, Su Z (2021) Surgery and medical treatment in microprolactinoma: A systematic review and meta-analysis. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2021\/9930059","journal-title":"Int J Endocrinol"},{"key":"1230_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00636","author":"Q Ma","year":"2018","unstructured":"Ma Q, Su J, Li Y, Wang J, Long W, Luo M, Liu Q (2018) The chance of permanent cure for micro- and macroprolactinomas, medication or surgery? A systematic review and meta-analysis. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2018.00636","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1230_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133252","author":"PP Mattogno","year":"2021","unstructured":"Mattogno PP, D\u2019Alessandris QG, Chiloiro S, Bianchi A, Giampietro A, Pontecorvi A, De Marinis L, Olivi A, Anile C, Lauretti L (2021) Reappraising the role of trans-sphenoidal surgery in prolactin-secreting pituitary tumors. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13133252","journal-title":"Cancers (Basel)"},{"key":"1230_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy385","author":"A Micko","year":"2019","unstructured":"Micko A, Vila G, Hoftberger R, Knosp E, Wolfsberger S (2019) Endoscopic transsphenoidal surgery of microprolactinomas: a reappraisal of cure rate based on radiological criteria. Neurosurgery. https:\/\/doi.org\/10.1093\/neuros\/nyy385","journal-title":"Neurosurgery"},{"key":"1230_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01168-x","author":"JY Park","year":"2021","unstructured":"Park JY, Choi W, Hong AR, Yoon JH, Kim HK, Jang WY, Jung S, Kang HC (2021) Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas. Pituitary. https:\/\/doi.org\/10.1007\/s11102-021-01168-x","journal-title":"Pituitary"},{"key":"1230_CR26","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e97","author":"K Park","year":"2021","unstructured":"Park K, Park KH, Park HR, Lee JM, Kim YH, Kim DY, Won TB, Kong SH, Kim JH, Shin CS, Paek SH (2021) Long-term outcome of microscopic transsphenoidal surgery for prolactinomas as an alternative to dopamine agonists. J Korean Med Sci. https:\/\/doi.org\/10.3346\/jkms.2021.36.e97","journal-title":"J Korean Med Sci"},{"key":"1230_CR27","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab074","author":"MC Penn","year":"2021","unstructured":"Penn MC, Cardinal T, Zhang Y, Abt B, Bonney PA, Lorenzo P, Lin M, Rosner J, Weiss M, Zada G, Carmichael JD (2021) Cure and hormonal control after prolactinoma resection: case series and systematic review. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvab074","journal-title":"J Endocr Soc"},{"key":"1230_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-021-00309-y","author":"L Wei","year":"2021","unstructured":"Wei L, Wei X (2021) Outcomes of transsphenoidal surgery in dopamine agonist-resistant prolactinomas: a retrospective study. Hormones (Athens). https:\/\/doi.org\/10.1007\/s42000-021-00309-y","journal-title":"Hormones (Athens)"},{"key":"1230_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00439","author":"G Zielinski","year":"2020","unstructured":"Zielinski G, Ozdarski M, Maksymowicz M, Szamotulska K, Witek P (2020) Prolactinomas: prognostic factors of early remission after transsphenoidal surgery. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2020.00439","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1230_CR30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0977","author":"R Cozzi","year":"2022","unstructured":"Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M, Ciccarelli E, De Marinis L, De Menis E, Faustini Fustini M, Grimaldi F, Lania A, Lasio G, Logoluso F, Losa M, Maffei P, Milani D, Poggi M, Zini M, Katznelson L, Luger A, Poiana C (2022) Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-21-0977","journal-title":"Eur J Endocrinol"},{"key":"1230_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1882-0","author":"BN Tang","year":"2006","unstructured":"Tang BN, Levivier M, Heureux M, Wikler D, Massager N, Devriendt D, David P, Dumarey N, Corvilain B, Goldman S (2006) 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-005-1882-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1230_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2013.11.011","author":"S Rodriguez-Barcelo","year":"2014","unstructured":"Rodriguez-Barcelo S, Gutierrez-Cardo A, Dominguez-Paez M, Medina-Imbroda J, Romero-Moreno L, Arraez-Sanchez M (2014) Clinical usefulness of coregistered 11C-methionine positron emission tomography\/3-T magnetic resonance imaging at the follow-up of acromegaly. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2013.11.011","journal-title":"World Neurosurg"},{"key":"1230_CR33","doi-asserted-by":"publisher","DOI":"10.1159\/000095529","author":"C Muhr","year":"2006","unstructured":"Muhr C (2006) Positron emission tomography in acromegaly and other pituitary adenoma patients. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000095529","journal-title":"Neuroendocrinology"},{"key":"1230_CR34","doi-asserted-by":"publisher","DOI":"10.3171\/2009.7.Jns09285","author":"H Ikeda","year":"2010","unstructured":"Ikeda H, Abe T, Watanabe K (2010) Usefulness of composite methionine-positron emission tomography\/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma. J Neurosurg. https:\/\/doi.org\/10.3171\/2009.7.Jns09285","journal-title":"J Neurosurg"},{"key":"1230_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000001085","author":"Z Feng","year":"2016","unstructured":"Feng Z, He D, Mao Z, Wang Z, Zhu Y, Zhang X, Wang H (2016) Utility of 11C-methionine and 18F-FDG PET\/CT in patients with functioning pituitary adenomas. Clin Nucl Med. https:\/\/doi.org\/10.1097\/rlu.0000000000001085","journal-title":"Clin Nucl Med"},{"key":"1230_CR36","first-page":"610","volume":"32","author":"M Bergstr\u00f6m","year":"1991","unstructured":"Bergstr\u00f6m M, Muhr C, Lundberg PO, L\u00e5ngstr\u00f6m B (1991) PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med 32:610","journal-title":"J Nucl Med"},{"key":"1230_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-198709000-00014","author":"M Bergstrom","year":"1987","unstructured":"Bergstrom M, Muhr C, Lundberg PO, Bergstrom K, Gee AD, Fasth KJ, Langstrom B (1987) Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study. J Comput Assist Tomogr. https:\/\/doi.org\/10.1097\/00004728-198709000-00014","journal-title":"J Comput Assist Tomogr"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01230-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T10:21:27Z","timestamp":1659435687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01230-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01230-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"6 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data of patients were obtained after a waiver of the medical ethical review was received from our institutional medical ethical review board (G19.011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A declaration of non-objection was obtained for review of patients\u2019 charts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"A declaration of non-objection was obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}